Humana (NYSE:HUM) Reaches New 52-Week Low – Here’s What Happened

Humana Inc. (NYSE:HUM) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $163.11 and last traded at $166.1230, with a volume of 179338 shares. The stock had previously closed at $166.45.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HUM shares. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 price objective on shares of Humana in a research note on Tuesday, January 6th. Barclays reduced their target price on Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 24th. TD Cowen lowered their price target on Humana from $260.00 to $173.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Cantor Fitzgerald dropped their price target on Humana from $290.00 to $201.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. Finally, The Goldman Sachs Group cut their price objective on Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Seven investment analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $225.48.

Humana Price Performance

The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock’s 50 day moving average price is $202.16 and its two-hundred day moving average price is $243.22. The stock has a market cap of $20.40 billion, a price-to-earnings ratio of 17.31, a price-to-earnings-growth ratio of 1.82 and a beta of 0.44.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm’s quarterly revenue was up 11.3% on a year-over-year basis. During the same period in the previous year, the firm posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. Humana’s dividend payout ratio is presently 36.05%.

Insider Buying and Selling

In related news, insider Sanjay K. Shetty bought 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Humana

Several hedge funds have recently bought and sold shares of HUM. Vanguard Group Inc. increased its holdings in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after purchasing an additional 106,030 shares in the last quarter. Dodge & Cox boosted its holdings in Humana by 5.6% during the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock worth $2,775,562,000 after buying an additional 597,705 shares in the last quarter. Capital International Investors grew its position in Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares during the period. State Street Corp grew its position in Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its holdings in Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.